COLLEGIUM PHARMACEUTICAL, INC: STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp disclosed a stake exceeding 5% in Collegium Pharmaceutical Inc. via a Schedule 13G filing with the SEC (accession 0000093751-26-000632). The filing signals that the institutional investor has crossed the key 5% ownership threshold, making it a reportable beneficial owner under SEC rules. The exact share count and percentage were not specified in the headline disclosure. The move matters because large institutional holders can influence governance and signal confidence in the specialty pharma company. Investors will watch for further 13G/13D amendments for precise position sizing and any changes in State Street's holdings.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Collegium Pharmaceutical, Inc., State Street Corp